---
figid: PMC4956935__JCMM-20-1589-g002
figlink: /pmc/articles/PMC4956935/figure/jcmm12845-fig-0002/
number: Figure 2
caption: Proposed IGF‐interaction with PPAR‐γ signalling in CVD epigenetics. Interaction
  between PPAR‐γ and MAPK/PI3K pathways happens at different levels or time points
  in the cell cycle, thus in certain situations PPAR‐γ reduces the expression of MEK1/2
  protein expression and inhibits ERK1/2 phosphorylation , , . In contrast, in other
  cell systems, PPAR‐γ may activate ERK1/2. Furthermore, the interaction between PPAR‐γ
  and MAPK/PI3K may include pathways where ERK mediates PPAR‐γ phosphorylation, MEK1/2‐dependent
  PPAR‐γ nuclear export followed by PPAR‐γ degradation, PI3K inhibition through PTEN,
  mTOR decrease by AMPK activation and finally p70S6K phosphorylation. This signalling
  loop can be potentially responsible for epigenetic activity that targets survival,
  proliferation and/or differentiation of cardiac cells. Physical effort has been
  shown to increase levels of IGF‐I in muscle and physiological cardiac hypertrophy,
  thus inducing the IGF‐I/PI3K/Akt/P70S6K signalling pathway, and thereby increasing
  the protein synthesis required to build muscle; all of this can be epigenetically
  regulated , , , . On the other hand, PPAR‐γ ligands (such as rosiglitazone) activate
  tuberous sclerosis complex‐2 (TSC2) inhibiting mTOR signalling ,  as a possible
  compensatory effect to the MEK/ERK action on PPAR‐γ.
pmcid: PMC4956935
papertitle: Insulin‐like growth factors and their potential role in cardiac epigenetics.
reftext: Cristiana Iosef Husted, et al. J Cell Mol Med. 2016 Aug;20(8):1589-1602.
pmc_ranked_result_index: '10828'
pathway_score: 0.9400392
filename: JCMM-20-1589-g002.jpg
figtitle: Proposed IGF‐interaction with PPAR‐G signalling in CVD epigenetics
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4956935__JCMM-20-1589-g002.html
  '@type': Dataset
  description: Proposed IGF‐interaction with PPAR‐γ signalling in CVD epigenetics.
    Interaction between PPAR‐γ and MAPK/PI3K pathways happens at different levels
    or time points in the cell cycle, thus in certain situations PPAR‐γ reduces the
    expression of MEK1/2 protein expression and inhibits ERK1/2 phosphorylation ,
    , . In contrast, in other cell systems, PPAR‐γ may activate ERK1/2. Furthermore,
    the interaction between PPAR‐γ and MAPK/PI3K may include pathways where ERK mediates
    PPAR‐γ phosphorylation, MEK1/2‐dependent PPAR‐γ nuclear export followed by PPAR‐γ
    degradation, PI3K inhibition through PTEN, mTOR decrease by AMPK activation and
    finally p70S6K phosphorylation. This signalling loop can be potentially responsible
    for epigenetic activity that targets survival, proliferation and/or differentiation
    of cardiac cells. Physical effort has been shown to increase levels of IGF‐I in
    muscle and physiological cardiac hypertrophy, thus inducing the IGF‐I/PI3K/Akt/P70S6K
    signalling pathway, and thereby increasing the protein synthesis required to build
    muscle; all of this can be epigenetically regulated , , , . On the other hand,
    PPAR‐γ ligands (such as rosiglitazone) activate tuberous sclerosis complex‐2 (TSC2)
    inhibiting mTOR signalling ,  as a possible compensatory effect to the MEK/ERK
    action on PPAR‐γ.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - IGF1
  - RAF1
  - ARAF
  - IGF2
  - HRAS
  - PIK3R3
  - PIK3CG
  - BRAF
  - PIK3R5
  - MAP2K1
  - MAP2K2
  - MAPK3
  - PIK3CD
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - MTOR
  - AKT3
  - AKT1
  - MAPK1
  - NRAS
  - RHEB
  - TSC1
  - TSC2
  - AKT2
  - RPS6KB2
  - PIK3R6
  - KRAS
  - RPS6KB1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IGF-I
  symbol: IGF-I
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: IGF-II
  symbol: IGF-II
  source: hgnc_alias_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Ras/Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Ras/Raf
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
